Prestige Consumer Healthcare (PBH) investor relations material

Strategic overview and business model

• Focus on long-term brand building in stable OTC healthcare categories, avoiding direct competition and prioritizing brands that define their space.

• Emphasis on disciplined capital allocation, including reducing leverage to historic lows, significant stock buybacks, and active acquisitions.

• Recent acquisitions include a sterile eye care partner for supply chain control, Breathe Right (largest deal at $1B), and LaCorium Health, an Australian skincare business.

• Long-term growth has averaged nearly 10% top line and mid-teens bottom line over 15–20 years.

Consumer and retail trends

• Consumers increasingly seek better price-value propositions, shifting toward mass and e-commerce channels, while drug and regional grocers face headwinds.

• Retailer inventory levels remain stable and aligned with consumption, with little volatility observed in core categories.

• Competitive landscape remains unchanged, with strong brand loyalty in niche categories and minimal private label threat.

Cost structure and inflation management

• Freight costs are a low single-digit percentage of sales, with most COGS tied to labor; exposure to oil price inflation is manageable.

• Cost-saving plans and selective pricing actions are in place to offset inflation, with most production based in North America providing insulation.